International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
复制标题
DOI：
10.1111/j.2040-1124.2012.00207.x
复制
发表时间：
2012-02-01
影响因子：
3.2
通讯作者：
Ohashi, Hatsumi
中科院分区：
文献类型：
--
作者：
Kashiwagi, Atsunori;Kasuga, Masato;Ohashi, Hatsumi
1999年，日本糖尿病学会(JDS)推出了早期版本的糖尿病诊断标准，其中JDS主动采用糖化血红蛋白(HbA1c)作为糖尿病诊断的辅助指标。相比之下，2009年，由美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)成员组成的国际专家委员会根据表明HbA1c作为慢性高血糖标志物有几个优势的最新证据，提出了将HbA1c用作糖尿病诊断的替代方法的建议[1-3]。JDS根据日本的流行病学数据，广泛评估了HbA1c在糖尿病诊断中更广泛使用的有用性和可行性，然后在《国际糖尿病》[4]和《糖尿病调查杂志》[5]上发表了《糖尿病分类和诊断标准委员会报告》。日本的新诊断标准于2010年7月1日生效。根据
In 1999, the Japan Diabetes Society (JDS) launched the previous version of the diagnostic criteria of diabetes mellitus, in which JDS took initiative in adopting glycated haemoglobin (HbA1c) as an adjunct to the diagnosis of diabetes. In contrast, in 2009 the International Expert Committee composed of the members of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) manifested the recommendation regarding the use of HbA1c in diagnosing diabetes mellitus as an alternative to glucose measurements based on the update evidences indicating that HbA1c has several advantages as a marker of chronic hyperglycemia [1–3]. The JDS extensively evaluated the usefulness and feasibility of more extended use of HbA1c in the diagnosis of diabetes based on Japanese epidemiological data, and then the ‘‘Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus’’was published in the Diabetology International [4] and Journal of Diabetes Investigation [5]. The new diagnostic criterion in Japan came into effect on July 1, 2010. According to the